Antioxidant power of angiotensin‐converting enzyme inhibitors in vitro

IFF Benzie, B Tomlinson - British journal of clinical …, 1998 - Wiley Online Library
British journal of clinical pharmacology, 1998Wiley Online Library
Aims There is controversy regarding the potential antioxidant effect of captopril, therefore
this study was performed to compare the in vitro antioxidant power of captopril with other
angiotensin‐converting enzyme (ACE) inhibitors. Methods Antioxidant power of captopril,
enalapril, fosinopril, perindopril, quinapril and ramipril in aqueous solution was measured
using the ferric reducing (antioxidant) power (FRAP) assay; captopril was also measured in
ethanolic solution. Results Only captopril showed significant antioxidant power …
Aims  There is controversy regarding the potential antioxidant effect of captopril, therefore this study was performed to compare the in vitro antioxidant power of captopril with other angiotensin‐converting enzyme (ACE) inhibitors.
Methods  Antioxidant power of captopril, enalapril, fosinopril, perindopril, quinapril and ramipril in aqueous solution was measured using the ferric reducing (antioxidant) power (FRAP) assay; captopril was also measured in ethanolic solution.
Results  Only captopril showed significant antioxidant power, demonstrating a stoichiometric factor of 1.0 in this assay. Concentration‐related antioxidant power was seen in both aqueous and ethanolic solutions.
Conclusions  Captopril shows antioxidant activity in vitro. This property could be relevant in vivo if captopril is concentrated in membranes, lipoproteins or at other important sites.
Wiley Online Library